Literature DB >> 11991756

Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap.

Guang-ping Gao1, Fengmin Lu, Julio C Sanmiguel, Phoi T Tran, Zahra Abbas, Kimberly S Lynd, Jon Marsh, Nancy B Spinner, James M Wilson.   

Abstract

Cell lines stably expressing rep/cap are important tools for studying adeno-associated virus (AAV) biology and producing AAV vectors. Several rep/cap cell lines have been isolated, each of which is based on HeLa cells. Infection of these cell lines with adenovirus for production of AAV vector is associated with substantial amplification of the rep/cap gene. Concerns over the presence of human papilloma viral (HPV) sequences in HeLa cells may limit use of such lines for production of clinical-grade vectors. Here we describe a non-HeLa-derived rep/cap cell line called K209, generated by stable transfection of A549 cells with a plasmid construct containing the P5 rep/cap cassette from AAV2. Infection of K209 cells with adenovirus leads to a 1000-fold amplification of the rep/cap gene with high-yield production of AAV vectors. The multiplicity of infection (MOI) of adenovirus that led to maximum amplification of the rep/cap gene and high-level production of AAV is 10 times higher in the HeLa-based cell line than that required in K209 cells. Our data suggest that papilloma-derived gene products present in HeLa cells are not required for high-yield production of AAV vectors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991756     DOI: 10.1006/mthe.2001.0591

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  19 in total

1.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

2.  AAV-mediated targeting of gene expression to the peri-infarct region in rat cortical stroke model.

Authors:  Kert Mätlik; Usama Abo-Ramadan; Brandon K Harvey; Urmas Arumäe; Mikko Airavaara
Journal:  J Neurosci Methods       Date:  2014-08-23       Impact factor: 2.390

3.  Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice.

Authors:  Carmen Unzu; Ana Sampedro; Itsaso Mauleón; Manuel Alegre; Stuart G Beattie; Rafael Enríquez de Salamanca; Jolanda Snapper; Jaap Twisk; Harald Petry; Gloria González-Aseguinolaza; Julio Artieda; María Sol Rodríguez-Pena; Jesús Prieto; Antonio Fontanellas
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

4.  Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice.

Authors:  Shih-Wen Lin; Scott E Hensley; Nia Tatsis; Marcio O Lasaro; Hildegund C J Ertl
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

5.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

6.  Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells.

Authors:  C Jenny; E Toublanc; O Danos; O-W Merten
Journal:  Cytotechnology       Date:  2005-09       Impact factor: 2.058

7.  Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury.

Authors:  Mikko Airavaara; Matt J Chiocco; Doug B Howard; Katie L Zuchowski; Johan Peränen; Chao Liu; Shengyun Fang; Barry J Hoffer; Yun Wang; Brandon K Harvey
Journal:  Exp Neurol       Date:  2010-06-02       Impact factor: 5.330

8.  Four-dimensional visualization of the simultaneous activity of alternative adeno-associated virus replication origins.

Authors:  Daniel L Glauser; Okay Saydam; N Alexander Balsiger; Irma Heid; R Michael Linden; Mathias Ackermann; Cornel Fraefel
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.

Authors:  Manuela Corti; Cristina Liberati; Barbara K Smith; Lee Ann Lawson; Ibrahim S Tuna; Thomas J Conlon; Kirsten E Coleman; Saleem Islam; Roland W Herzog; David D Fuller; Shelley W Collins; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2017-12       Impact factor: 5.032

10.  cis effects in adeno-associated virus type 2 replication.

Authors:  Peter Ward; Nathalie Clément; R Michael Linden
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.